Overview

Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients

Status:
Completed
Trial end date:
2000-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess a possible predictor for weight loss seen in epilepsy patients treated with topiramate.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Treatments:
Topiramate